Trial Information

Summary: Study to Assess the Safety and Efficacy of Multiple Dosing Regimens of IV Conivaptan in people with Euvolemic Hyponatremia.

People currently experiencing euvolemic hyponatremia are asked to participate in a research study being conducted by Jacobi Medical Center. Euvolemic hyponatremia means having low salt in the blood along with increased total body water without signs of hypervolemia (e.g. swelling or puffiness which can cause dimpling of the skin)

You may be eligible to participate in this study if you:

  • Are at least 18 years of age

You may not participate in this study if you:

  • Have Congestive Heart Failure
  • Are pregnant/breastfeeding or intend to become pregnant during the study
  • Have participated in another research study within the last 30 days

For more information,

Contact:

Cinthi Pillai, Study Coordinator
Biomedical Research Alliance of New York
Jacobi Medical Center
1400 Pelham Parkway South
Bronx, NY 10461
Telephone: 718-918-3577
Email:

Profile Page: Biomedical Research Alliance of New York, Bronx, NY

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:


Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:30:42 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA